Sur A, Iflazoglu Mutlu S, Tatli Seven P, Seven I, Aslan A, Kizil M
Toxicol Res. 2023; 39(4):749-759.
PMID: 37779581
PMC: 10541365.
DOI: 10.1007/s43188-023-00196-y.
Meunier L, Larrey D
Int J Mol Sci. 2023; 24(1).
PMID: 36614299
PMC: 9821303.
DOI: 10.3390/ijms24010852.
Zheng G, Ma H, Xiang G, He G, Cai H, Dai Z
J Nanobiotechnology. 2022; 20(1):220.
PMID: 36310171
PMC: 9620632.
DOI: 10.1186/s12951-022-01400-1.
Shuker E, Farhood M, Al-Qudaihi G, Fouad D
Dose Response. 2022; 20(1):15593258221082877.
PMID: 35360456
PMC: 8961387.
DOI: 10.1177/15593258221082877.
Zoubek M, Pinazo-Bandera J, Ortega-Alonso A, Hernandez N, Crespo J, Contreras F
United European Gastroenterol J. 2019; 7(6):825-837.
PMID: 31316787
PMC: 6620870.
DOI: 10.1177/2050640619840147.
Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis.
Rotondo E, Graziosi A, Di Stefano V, Mohn A
BMJ Case Rep. 2018; 11(1).
PMID: 30567201
PMC: 6301543.
DOI: 10.1136/bcr-2018-226687.
Recent Advances in the Histopathology of Drug-Induced Liver Injury.
Kleiner D
Surg Pathol Clin. 2018; 11(2):297-311.
PMID: 29751876
PMC: 5953206.
DOI: 10.1016/j.path.2018.02.009.
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.
Nociti V, Biolato M, De Fino C, Bianco A, Losavio F, Lucchini M
Brain Behav. 2018; 8(6):e00968.
PMID: 29729087
PMC: 5991562.
DOI: 10.1002/brb3.968.
Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse.
Bresteau C, Prevot S, Perlemuter G, Voican C
BMJ Case Rep. 2018; 2018.
PMID: 29507031
PMC: 5847962.
DOI: 10.1136/bcr-2017-223670.
Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.
Sarges P, Steinberg J, Lewis J
Drug Saf. 2016; 39(9):801-21.
PMID: 27142208
DOI: 10.1007/s40264-016-0427-8.
